Zimbabwe has turned down a substantial American healthcare agreement valued at $367m (272 million pounds) spanning five years over Washington's insistence on sensitive biological samples.
This move became public following a government memo from December was leaked, which showed President Emmerson Mnangagwa felt the agreement was "unbalanced".
An official spokesman later stated that the United States was seeking genetic material for research and commercial gain while was unwilling to share the benefits from future treatments.
"We must now begin the difficult and regrettable process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for further talks to reach a deal suitable to all parties so the country's critical HIV programme can be sustained.
Wider Context
This rejection comes after a comparable situation in neighbouring Kenya, where a court halted a related health funding agreement after concerns were filed about the security of citizens' medical information.
Since returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump claimed its spending was "wasteful" and his administration was pursuing direct bilateral deals to enhance transparency and accountability.
As per reports, Sixteen African countries have so far agreed to these new agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Deal
The funds for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"Our nation was requested to provide its genetic material and health information for a long time, with no corresponding guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"Effectively, our nation would supply the raw materials for scientific discovery without any certainty that the end products would be accessible to our population should a new pandemic arise."
National Interest and Global Health
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were undermining systems already established via the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with future pandemics.
"This framework is designed to guarantee that when a nation contributes its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We welcome further discussions with our American counterparts on how subsequent co-operation could be structured in a way that respects the sovereignty and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but suggested that negotiations need to persist since much of the country's Aids initiatives were funded by foreign aid.
"In cases where specific concerns arise, such as those relating to data governance or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," the group added.
This impasse underscores the complex debate between receiving much-needed foreign assistance and safeguarding local interests in an ever more interconnected world.